A drug manufacturer is asking the Supreme Court to preserve access to its abortion pill free from restrictions imposed by lower court rulings, while a legal fight continues.
In an order signed by Justice Samuel Alito, the court asked both sides to weigh in by Tuesday over whether lower court rulings restricting the Food and Drug Administration’s approval of the drug, mifepristone, should be allowed to take effect while the case works its way through federal courts. The order suggests the court will decide that issue by late Wednesday.
"This application concerns unprecedented lower court orders countermanding FDA’s scientific judgment and unleashing regulatory chaos by suspending the existing FDA-approved conditions of use for mifepristone," Solicitor General Elizabeth Prelogar, the Biden administration's top Supreme Court lawyer, wrote Friday, less than two days after the appellate ruling.
The court rarely acts so quickly to grant full review of cases before at least one appeals court has thoroughly examined the legal issues involved. Erin Hawley, a lawyer for the challengers, said in a statement that the FDA has put politics ahead of health concerns in its actions on medication abortion.
It’s unclear how the FDA can comply with court orders in both cases, a situation that Prelogar described Friday as untenable.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Supreme Court keeps FDA abortion pill rules in place for nowThe Supreme Court has temporarily kept in place federal rules for use of an abortion drug, while it more fully considers the issues raised in a court challenge. The court asked both sides Friday to weigh in over whether lower court rulings restricting the Food and Drug Administration’s approval of mifepristone should be allowed to take effect while the case proceeds in federal courts. The justices are being asked to determine what parts of an April 7 ruling by a U.S. district judge in Texas, as modified by an appellate ruling Wednesday, can be in force while the case continues. The Biden administration and New York-based drugmaker Danco Laboratories asked the justices to intervene.
Read more »
Supreme Court keeps FDA abortion pill rules in place for nowThe Supreme Court said Friday it was temporarily keeping in place federal rules for use of an abortion drug, while it takes time to more fully consider the issues raised in a court challenge.
Read more »
Supreme Court keeps FDA abortion pill rules in place for nowThe Supreme Court said Friday it was temporarily keeping in place federal rules for use of an abortion drug, while it takes time to more fully consider the issues raised in a court challenge.
Read more »
Abortion issue returns to Supreme Court as DOJ fights ruling on FDA’s pill approvalThe Biden administration will ask the Supreme Court to lift newly imposed court restrictions on a popular abortion pill, sending the pregnancy-termination issue back to the high court less than a year after its historic decision overturning Roe v. Wade was supposed to return the issue to the states to regulate.
Read more »
Justice Dept. and drugmaker ask Supreme Court to block abortion pill ruling against FDAThe Justice Department and Danco Laboratories, which makes Mifeprex, have appealed to the Supreme Court to temporarily block and then overturn the Texas ruling that invalidated the FDA's approval of the abortion drug and severely restricted access to the pill. NBC News' Laura Jarrett has more details.
Read more »
DOJ asks Supreme Court to block federal court rulings restricting abortion pillsNEW: The Justice Department asked the Supreme Court to block federal court rulings that imposed restrictions on the widely used abortion pill mifepristone.
Read more »